BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 10, Issue 19
This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (23287)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.
Item 
Count 
PDF1194
WORD169
HTML19610
Figures (1-1)328
Tables (1-1)426
 Sum=21727
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse432
Download1128
 Sum=1560
Jul 6, 2022 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Cho JH, Jin SY. Current guidelines for Helicobacter pylori treatment in East Asia 2022: Differences among China, Japan, and South Korea. World J Clin Cases 2022; 10(19): 6349-6359 [PMID: 35979311 DOI: 10.12998/wjcc.v10.i19.6349]
URL: https://www.wjgnet.com/1007-9327/full/v10/i19/6349.htm
Number Citing Articles
1
Shan Huang, Bo Li, Xue-Yao Pang, Wei-Wei Gao. Efficacy and safety of Vonoprazan-based treatment of Helicobacter pylori infection: a systematic review and network meta-analysis. BMC Infectious Diseases 2024; 24(1) doi: 10.1186/s12879-024-09885-x
2
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki. Helicobacter pylori and gastric cancer: a critical approach to who really needs eradication. Exploration of Digestive Diseases 2024; : 107 doi: 10.37349/edd.2024.00043
3
Charlene Deane, Orlaith Kelly, Colm O’Morain. Current and Future Perspectives on the Management of Helicobacter pylori: A Narrative Review. Antibiotics 2024; 13(6): 541 doi: 10.3390/antibiotics13060541
4
Vaneet Jearth, Ashutosh Ishan Yadav, Jimil Shah, Anupam Kumar Singh, Sridhar Sundaram, Vishal Sharma, Usha Dutta, Govind Makharia, Manas Kumar Panigrahi. A survey of practice patterns and adherence to national and international guidelines on the management of Helicobacter pylori infection among gastroenterologists and gastroenterology fellows in India. Indian Journal of Gastroenterology 2024;  doi: 10.1007/s12664-024-01694-z
5
А. S. Tertychnyy, Т. L. Lapina, D. Р. Nagornaya, N. V. Pachuashvili, А. Р. Kiryukhin, А. А. Fedorenko, Р. V. Pavlov, D. D. Protsenko, V. Т. Ivashkin. Spectrum of Chronic Gastritis Based on Morphological Examination of Gastric Biopsies. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2024; 34(2): 45 doi: 10.22416/1382-4376-2024-34-2-45-56
6
Chelsea S. Taylor, Mercedes V. McMahon, Zachary J. Ward, Fernando Alarid-Escudero, M. Constanza Camargo, Monika Laszkowska, Jorge Roa, Jennifer M. Yeh. Birth cohort and age-specific trends in global Helicobacter pylori seroprevalence: a scoping review. The Lancet Regional Health - Americas 2024; : 100877 doi: 10.1016/j.lana.2024.100877
7
Yujie Cheng, Lin Yang, Si Xu, Chong Zhang. Vonoprazan is Not Inferior to Proton Pump Inhibitors in Bismuth-containing Quadruple Therapy for Helicobacter pylori Eradication. Journal of Clinical Gastroenterology 2024; 58(10): 950 doi: 10.1097/MCG.0000000000002001
8
György Miklós Buzás, Péter Birinyi. Newer, Older, and Alternative Agents for the Eradication of Helicobacter pylori Infection: A Narrative Review. Antibiotics 2023; 12(6): 946 doi: 10.3390/antibiotics12060946
9
Lyudmila Boyanova, Petyo Hadzhiyski, Raina Gergova, Rumyana Markovska. Evolution of Helicobacter pylori Resistance to Antibiotics: A Topic of Increasing Concern. Antibiotics 2023; 12(2): 332 doi: 10.3390/antibiotics12020332
10
Bao Le, Duy Thanh Do, Hien Minh Nguyen, Bich Hang Do, Huong Thuy Le. Preparation, Characterization, and Anti-Adhesive Activity of Sulfate Polysaccharide from Caulerpa lentillifera against Helicobacter pylori. Polymers 2022; 14(22): 4993 doi: 10.3390/polym14224993
11
Nur Izreena Ismail, Khairul Najmi Muhammad Nawawi, Deborah Chew Chia Hsin, Kok Wei Hao, Nik Ritza Kosai Nik Mahmood, Gary Lee Chong Chearn, Zhiqin Wong, Azmi Mohd Tamil, Hazel Joseph, Raja Affendi Raja Ali. Probiotic containing Lactobacillus reuteri DSM 17648 as an adjunct treatment for Helicobacter pylori infection: A randomized, double‐blind, placebo‐controlled trial. Helicobacter 2023; 28(6) doi: 10.1111/hel.13017
12
Monica Contreras, Heisser Mujica, María Alexandra García-Amado. Molecular tools of antibiotic resistance for Helicobacter pylori: an overview in Latin America. Frontiers in Gastroenterology 2024; 3 doi: 10.3389/fgstr.2024.1410816
13
Jahirul Md Islam, Yukari Yano, Aoi Okamoto, Reimi Matsuda, Masaya Shiraishi, Yusuke Hashimoto, Nanaka Morita, Hironobu Takeuchi, Narufumi Suganuma, Hiroaki Takeuchi. Evidence of Helicobacter pylori heterogeneity in human stomachs by susceptibility testing and characterization of mutations in drug-resistant isolates. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-62200-1
14
Elizabeth Garvey, Joanne Rhead, Suffi Suffian, Daniel Whiley, Farah Mahmood, Naveen Bakshi, Darren Letley, Jonathan White, John Atherton, Jody Anne Winter, Karen Robinson. High incidence of antibiotic resistance amongst isolates of Helicobacter pylori collected in Nottingham, UK, between 2001 and 2018.  Journal of Medical Microbiology 2023; 72(11) doi: 10.1099/jmm.0.001776
15
Ju Yup Lee. Helicobacter pylori. 2023; : 607 doi: 10.1007/978-981-97-0013-4_51
16
Inna A. Oganezova, Liya N. Belousova, Igor G. Bakulin. Modern approaches to the eradication of <i>Helicobacter pylori</i>: a spectrum of perspectives. Russian Family Doctor 2024; 28(3): 24 doi: 10.17816/RFD634209
17
梅 韩. Study on the Helicobacter pylori Infection and the Correlation Study of Anxiety-Depression Condition. Advances in Clinical Medicine 2023; 13(08): 13671 doi: 10.12677/ACM.2023.1381910
18
Taslima Zaman, Ahsanul Haq, Rahnuma Ahmad, Susmita Sinha, Kona Chowdhury, Sultana Parvin, Mostofa Imran, Zaman U Humayra, Santosh Kumar, Mainul Haque. The Role of Probiotics in the Eradication of Helicobacter pylori and Overall Impact on Management of Peptic Ulcer: A Study Involving Patients Undergoing Triple Therapy in Bangladesh. Cureus 2024;  doi: 10.7759/cureus.56283
19
Song-Wei Wang, Fang-Jung Yu, Fu-Chen Kuo, Jiunn-Wei Wang, Yao-Kuang Wang, Yi-Hsun Chen, Wen-Hung Hsu, Chung-Jung Liu, Deng-Chyang Wu, Chao-Hung Kuo. Rescue therapy for refractory Helicobacter pylori infection: current status and future concepts. Therapeutic Advances in Gastroenterology 2023; 16 doi: 10.1177/17562848231170941
20
Jun-Hyung Cho. Bismuth add-on improves the efficacy of 2-week tegoprazan-based triple therapy for first-line Helicobacter pylori eradication: a real-world evidence study . Expert Review of Anti-infective Therapy 2024; : 1 doi: 10.1080/14787210.2024.2329251
21
Yu-Hua Peng, Xue Feng, Zhong Zhou, Lei Yang, Yun-Fei Shi. <i>Helicobacter pylori</i> infection in Xinjiang Uyghur Autonomous Region: Prevalence and analysis of related factors. World Journal of Gastroenterology 2023; 29(43): 5834-5847 doi: 10.3748/wjg.v29.i43.5834
22
Xiaohua Hou, Jiangbin Wang, Qin Du, Dean Tian, Naizhong Hu, Deliang Liu, Fang Zhou, Li Xie, Liqun Gu, Kentarou Kudou, Shutian Zhang. Efficacy and Safety of Vonoprazan-Based Quadruple Therapy for the Eradication of <i>Helicobacter pylori</i> in Patients with Peptic Ulcers: A Pooled Analysis of Two Randomized, Double-Blind, Double-Dummy, Phase 3 Trials. Biological and Pharmaceutical Bulletin 2024; 47(8): 1405 doi: 10.1248/bpb.b24-00011
23
Raktim Swarnakar, Shiv Lal Yadav. “<i>Helicobacter pylori </i>treatment guideline: An Indian perspective”: Letter to the editor. World Journal of Clinical Cases 2022; 10(29): 10817-10819 doi: 10.12998/wjcc.v10.i29.10817
24
Jing Li, Huiying Shi, Fang Zhou, Li Xie, Rong Lin. The Efficacy and Safety of Regimens for Helicobacter pylori Eradication Treatment in China. Journal of Clinical Gastroenterology 2024; 58(1): 12 doi: 10.1097/MCG.0000000000001902
25
György Miklós Buzás. A káliumkompetitív savgátlók szerepe a felső emésztőtraktus savfüggő betegségeinek kezelésében. Orvosi Hetilap 2023; 164(50): 1967 doi: 10.1556/650.2023.32937
26
Elena A. Kupriyanova, Sayar R. Abdulkhakov, Ruzilya К. Ismagilova, Dilyara D. Safina, Alsu R. Akhtereeva, Raushania R. Galimova, Ayrat G. Safin, Tatiana V. Grigoryeva, Rustam А. Abdulkhakov. The prevalence of mutations underlying development of Helicobacter pylori resistance to antibiotics in Kazan. Terapevticheskii arkhiv 2024; 96(8): 739 doi: 10.26442/00403660.2024.08.202813
27
Yanmeng Wang, Yiling Li, Yuehua Gong, Yuzhen Dong, Jing Sun, Moye Chen. Antibiotic resistance characteristics and risk factors analysis of Helicobacter pylori strains isolated from patients in Liaoning Province, an area in North China. PeerJ 2023; 11: e15268 doi: 10.7717/peerj.15268
28
Irina Medakina, Larisa Tsapkova, Vera Polyakova, Sergey Nikolaev, Tatyana Yanova, Natalia Dekhnich, Igor Khatkov, Dmitry Bordin, Natalia Bodunova. Helicobacter pylori Antibiotic Resistance: Molecular Basis and Diagnostic Methods. International Journal of Molecular Sciences 2023; 24(11): 9433 doi: 10.3390/ijms24119433
29
Valerie Josephine Dirjayanto, Jessica Audrey, Daniel Martin Simadibrata. Vonoprazan-amoxicillin dual regimen with <i>Saccharomyces boulardii</i> as a rescue therapy for <i>Helicobacter pylori</i>: Current perspectives and implications. World Journal of Gastroenterology 2024; 30(10): 1280-1286 doi: 10.3748/wjg.v30.i10.1280
30
Theodore Rokkas, Konstantinos Ekmektzoglou. Advances in the pharmacological and regulatory management of multidrug resistant Helicobacter pylori . Expert Review of Clinical Pharmacology 2023; 16(12): 1229 doi: 10.1080/17512433.2023.2282061
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345